Estimaciones de analistas de Wall Street para NextCure, Inc. (NXTC): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-04 | $-0.90 | ||
| 2026-08-06 | $-2.80 | $-1.95 | -43.6% |
| 2026-05-07 | $-1.87 | $-1.81 | -3.3% |
| 2026-03-05 | $-0.81 | $-2.26 | +64.2% |
| 2025-11-05 | $-3.22 | $-4.06 | +20.7% |
| 2025-08-07 | $-11.29 | $-4.62 | -144.4% |
| 2025-05-01 | $-4.68 | $-4.80 | +2.5% |
| 2025-03-06 | $-4.92 | $-0.35 | -1305.7% |
Ratios de valoración
| Precio / Valor contable | 3.38 |
| EV / EBITDA | -0.42 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | $6.3M | $22.4M | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $582000 | $1.7M | $34.2M | $46.6M | 0 | 0 | 0 | 0 | $2.2M |
| Beneficio Bruto | -$582000 | -$1.7M | -$27.9M | -$24.2M | 0 | 0 | 0 | 0 | -$2.2M |
| I+D | $13.0M | $19.8M | $34.2M | $46.6M | $50.2M | $54.2M | $47.9M | $41.5M | $44.9M |
| Generales y Administrativos | $2.6M | $3.4M | $9.6M | $17.0M | $20.6M | $21.7M | $19.7M | $15.7M | $12.7M |
| Gastos Operativos | $15.5M | $23.2M | $9.6M | $17.0M | $70.8M | $75.9M | $67.6M | $59.7M | $55.4M |
| Beneficio Operativo | -$15.5M | -$23.2M | -$37.5M | -$41.2M | -$70.8M | -$75.9M | -$67.6M | -$59.7M | -$57.6M |
| EBITDA | -$15.0M | -$21.1M | -$34.8M | -$37.8M | -$65.1M | -$70.6M | -$59.0M | -$54.3M | -$53.7M |
| Gastos por Intereses | 0 | 0 | $209000 | $183000 | $77000 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$15.5M | -$22.8M | -$33.7M | -$36.6M | -$69.4M | -$74.7M | -$62.7M | -$55.7M | -$55.8M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$15.5M | -$22.8M | -$33.7M | -$36.6M | -$69.4M | -$74.7M | -$62.7M | -$55.7M | -$55.8M |
| BPA | $-8.17 | $-12.04 | $-25.79 | $-15.95 | $-30.15 | $-32.32 | $-27.04 | $-23.88 | $-19.65 |
| BPA Diluido | $-8.17 | $-12.04 | $-25.79 | $-15.95 | $-30.15 | $-32.32 | $-27.04 | $-23.88 | $-19.65 |
| Acciones en Circulación (Diluidas) | $1.9M | $1.9M | $1.3M | $2.3M | $2.3M | $2.3M | $2.3M | $2.3M | $2.8M |
Precio
| Precio | $6.03 |
| Capitalización | $22M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ANTX · BOLD · INTS · ITRM · JSPR · PLUR · PSTV
Explorar sector: Healthcare · Biotechnology
Más secciones de NXTC: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones